68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer
Autor: | Tobias Bäuerle, Michael Cordes, Alexander Cavallaro, Michael Beck, Philipp Ritt, Daniela Schmidt, Michael Uder, Olaf Prante, Peter J. Goebell, Christian Schmidkonz, Torsten Kuwert, Bernd Wullich, Theresa Ida Goetz |
---|---|
Rok vydání: | 2018 |
Předmět: |
Biochemical recurrence
PET-CT Chemotherapy business.industry medicine.medical_treatment Radiography General Medicine urologic and male genital diseases medicine.disease Confidence interval 030218 nuclear medicine & medical imaging Lesion 03 medical and health sciences Prostate cancer 0302 clinical medicine Docetaxel 030220 oncology & carcinogenesis medicine Radiology Nuclear Medicine and imaging medicine.symptom Nuclear medicine business medicine.drug |
Zdroj: | European Journal of Nuclear Medicine and Molecular Imaging. 45:1862-1872 |
ISSN: | 1619-7089 1619-7070 |
DOI: | 10.1007/s00259-018-4042-z |
Popis: | We aimed at evaluating the role of 68Ga-PSMA-11 PET/CT-derived metabolic parameters for assessment of whole-body tumor burden and its capability to determine therapeutic response in patients with prostate cancer. A total of 142 patients with biochemical recurrence of prostate cancer underwent PET/CT with [68Ga]Ga-PSMA-HBED-CC (68Ga-PSMA-11). Quantitative assessment of all 641 68Ga-PSMA-11-positive lesions in the field of view was performed to calculate PSMA-derived parameters, including whole-body PSMA tumor volume (PSMA-TV) and whole-body total lesion PSMA (TL-PSMA), as well as the established SUVmax and SUVmean values. All PET-derived parameters were tested for correlation with serum PSA levels and for association with Gleason scores. In 23 patients who underwent 68Ga-PSMA-11 PET/CT before and after therapy with either external beam radiation, androgen deprivation, or docetaxel chemotherapy, SUVmax and TL-PSMA were compared to radiographic response assessment of CT images based on RECIST 1.1 criteria and to biochemical response determined by changes of serum PSA levels. PSMA-TV and TL-PSMA demonstrated a significant correlation with serum PSA levels (P |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |